Stimulation of in-vitro angiogenesis by low concentrations of risedronate is mitigated by 1,25-dihydroxyvitamin D3 or 24,25-dihydroxyvitamin D3

GABRIEL DORADO PEREZ2026-01-292026-01-29201510.1016/j.jsbmb.2014.10.0182-s2.0-84924608379https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/25946BiochemistryCell BiologyClinical BiochemistryEndocrinologyEndocrinology, Diabetes and MetabolismMolecular BiologyMolecular MedicineStimulation of in-vitro angiogenesis by low concentrations of risedronate is mitigated by 1,25-dihydroxyvitamin D3 or 24,25-dihydroxyvitamin D3review article